Pyridone 6 is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets cAMP-dependent kinase, CDK2, Csk, FGFR, FGFR2, Flt-1, Flt-4, Fyn T, Hck, IκB kinase 2, and JAK2.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.